Download Files:
ALK kinase inhibitor-1
SKU
HY-19990-10 mg
Category Reference compound
Tags Anaplastic lymphoma kinase (ALK), Cancer, Protein Tyrosine Kinase/RTK
$50 – $295
Products Details
Product Description
– ALK kinase inhibitor-1 is an anaplastic lymphoma kinase (ALK) inhibitor extracted from patent US20130261106A1 compound I-202[1].
Web ID
– HY-19990
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C28H32FN5O3S
References
– [1]Carry JC, et, al. Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof. US20130261106A1.
CAS Number
– 1462949-64-9
Molecular Weight
– 537.65
Compound Purity
– 99.85
SMILES
– CN(CC1)CCN1C2=CC=C(NC3=NC=C4C(C(C5=C(OC)C=CC(F)=C5)=C(CO)S4)=N3)C(OC(C)C)=C2
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Anaplastic lymphoma kinase (ALK)
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.